Company Update

Genomic Valley Biotech's Registrar and Share Transfer Agent confirmed proper processing of securities for dematerialization during the quarter ended June 2026. This ensures physical shares submitted for electronic conversion were duly verified, mutilated, and cancelled.

The depositories' names were updated in the register of members within 15 days, and these securities are listed on stock exchanges.

This update highlights the company's continuous compliance and efficient management of its share registry, vital for investor trust and smooth share transactions.